Klor-con and Oxaprozin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Oxaprozin (oxaprozin). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Oxaprozin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Oxaprozin?

Oxaprozin has active ingredients of oxaprozin. It is often used in joint pain. eHealthMe is studying from 1,578 Oxaprozin users. Check the latest studies of Oxaprozin.



On Jul, 15, 2026

19 people who take Klor-con and Oxaprozin together, and have interactions are studied.

Klor-con and Oxaprozin drug interactions.

What are the common drug interactions of Klor-Con and Oxaprozin, by gender? *:

female:

  1. Chronic kidney disease
  2. Fatigue (feeling of tiredness)
  3. Headache (pain in head)
  4. Injection site erythema (redness at injection site)
  5. Renal failure (kidney dysfunction)
  6. Anaemia (lack of blood)
  7. Anxiety
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Depression
  10. Dizziness

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Affective disorder (mental disorder)
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Benign prostatic hyperplasia (benign enlargement of the prostate)
  8. Blood glucose increased
  9. Death
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Klor-Con and Oxaprozin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Death

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Joint swelling
  5. Pain
  6. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

60+:

  1. Chronic kidney disease
  2. Headache (pain in head)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Oedema peripheral (superficial swelling)
  6. Renal failure (kidney dysfunction)
  7. Staphylococcal skin infection (skin infection by an infection with staphylococcus bacteria)
  8. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  9. Injection site erythema (redness at injection site)
  10. Affective disorder (mental disorder)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 26.32%
  2. Pain: 4 people, 21.05%
  3. High Blood Pressure: 4 people, 21.05%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
  5. Multiple Myeloma (cancer of the plasma cells): 2 people, 10.53%
  6. Depression: 2 people, 10.53%
  7. High Blood Cholesterol: 2 people, 10.53%
  8. Insomnia (sleeplessness): 2 people, 10.53%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.53%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Oxaprozin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Klor-con and Oxaprozin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxaprozin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxaprozin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and oxaprozin (the active ingredients of Klor-con and Oxaprozin, respectively), and Klor-con and Oxaprozin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: